Arkin Bio Ventures is a Tel Aviv, Israel based venture capital firm founded in 2016. It is a part of Arkin Holdings.
The firm prefers to invest and support early and mid-stage companies that focus on immunotherapy, cancer, metabolism, microbiome, autoimmune diseases, and drug delivery platforms.
The notable investment portfolio of Arkin Bio Ventures includes ARTSaVIT, Keros Therapeutics, Metabomed, Oncorus, Pi Therapeutics, Werewolf Therapeutics. As of January 2020, Arkin Bio Ventures has made 10 investments.
Timeline
Invested in
Patents
Funding Rounds Participated In
Further Resources
Title
Author
Link
Type
Date
References
Organization
Investor
Company
Venture capital firmCompany attributes
Industry
Biotechnology
Autoimmune diseaseLocation
Tel AvivCompany Operating Status
Closed
Pitchbook URL
Founded Date
2016
Categories
Related Topics
Contributors
- 1
Lax Mariappan
Technopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry. - 2
Jed Christiansen
Director of Product and Data at Golden || Founder - Seed-DB. - 3
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 4
Katrina-Kay Pettitt
Data Duchess @ Golden - 5
Aime Anne Nisay
QA Engineer of web and mobile applications - 6
Duzenko Andrey
Extensive experience in development and interaction with the community - 7
Bhupendra Solanki
Researcher - 8
Henry Ogolla
Passionate about reading and writing. - 9
Rachel Phythian
Advisor / Investor
